0001483426-21-000002.txt : 20210202 0001483426-21-000002.hdr.sgml : 20210202 20210202162517 ACCESSION NUMBER: 0001483426-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210202 DATE AS OF CHANGE: 20210202 EFFECTIVENESS DATE: 20210202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MBio Diagnostics, Inc. CENTRAL INDEX KEY: 0001483426 IRS NUMBER: 300593627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-388194 FILM NUMBER: 21581772 BUSINESS ADDRESS: STREET 1: 5603 ARAPAHOE AVENUE STREET 2: SUITE 1 CITY: BOULDER STATE: CO ZIP: 80303 BUSINESS PHONE: 3039522905 MAIL ADDRESS: STREET 1: 5603 ARAPAHOE AVENUE STREET 2: SUITE 1 CITY: BOULDER STATE: CO ZIP: 80303 FORMER COMPANY: FORMER CONFORMED NAME: mBio Diagnostics, Inc. DATE OF NAME CHANGE: 20100204 D 1 primary_doc.xml X0708 D LIVE 0001483426 MBio Diagnostics, Inc. 5603 Arapahoe Avenue Suite 1 BOULDER CO COLORADO 80303 303-952-2905 DELAWARE mBio Diagnostics, Inc. Corporation true Christopher Myatt 5603 Arapahoe Avenue Suite 1 Boulder CO COLORADO 80303 Executive Officer Director Michael Chang 5603 Arapahoe Avenue Suite 1 Boulder CO COLORADO 80303 Director Robert Silverman 5603 Arapahoe Avenue Suite 1 Boulder CO COLORADO 80303 Director Andrew Drenick 5603 Arapahoe Avenue Suite 1 Boulder CO COLORADO 80303 Director Judith O'Brien 5603 Arapahoe Avenue Suite 1 Boulder CO COLORADO 80303 Director Other Technology Decline to Disclose 06b false 2021-02-01 false true true false 0 9990000 9990000 0 Securities issued include a promissory note in the aggregate principal amount of $9,000,000 and a warrant to purchase $990,000 of the company's Series B Preferred Stock or next round of Preferred Stock. false 1 0 0 0 false MBio Diagnostics, Inc. /s/ Christopher Myatt Christopher Myatt CEO, by Tyler Hayden, Attorney-in-Fact 2021-02-02